First Time Loading...

Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 26.325 EUR 0.32% Market Closed
Updated: Apr 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

116.3B
-0.8%
Assets
Growth Rates:
1 Year
-7%
3 Years
0%
5 Years
-8%
7 Years
+41%
10 Years
+127%
83.3B
-0.6%
Liabilities
Growth Rates:
1 Year
-3%
3 Years
-3%
5 Years
+3%
7 Years
+61%
10 Years
+172%
32.9B
-1%
Equity
Growth Rates:
1 Year
-15%
3 Years
+8%
5 Years
-28%
7 Years
+9%
10 Years
+59%

Balance Sheet Decomposition
Bayer AG

116.3B
Assets
83.3B
Liabilities
116.3B
Assets
83.3B
Liabilities
Current Assets 37.6B
Cash & Short-Term Investments 10.7B
Receivables 12.8B
Other Current Assets 14B
Non-Current Assets 78.7B
Long-Term Investments 3.1B
PP&E 13.3B
Intangibles 55.7B
Other Non-Current Assets 6.6B
Current Liabilities 29.5B
Accounts Payable 7.5B
Other Current Liabilities 22B
Non-Current Liabilities 53.9B
Long-Term Debt 38.2B
Other Non-Current Liabilities 15.7B

Balance Sheet
Bayer AG

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 853
1 859
1 899
7 581
4 052
3 185
4 191
4 564
5 171
5 907
Cash Equivalents
1 853
1 859
1 899
7 581
4 052
3 185
4 191
4 564
5 171
5 907
Short-Term Investments
204
272
3 525
1 517
950
2 219
7 692
3 175
4 982
4 680
Total Receivables
10 386
11 393
14 734
11 031
14 137
14 851
12 157
12 980
13 450
12 522
Accounts Receivables
9 097
9 933
10 969
8 582
11 714
11 678
9 552
10 047
10 312
9 343
Other Receivables
1 289
1 460
3 765
2 449
2 423
3 173
2 605
2 933
3 138
3 179
Inventory
8 478
8 550
8 408
6 550
11 132
10 650
10 961
11 314
13 636
13 947
Other Current Assets
632
1 747
1 881
3 394
794
1 534
674
545
521
500
Total Current Assets
22 227
23 821
30 447
30 073
31 065
32 439
35 675
32 578
37 760
37 556
PP&E Net
11 428
12 375
13 114
7 633
12 943
12 479
11 723
12 688
13 674
13 321
PP&E Gross
11 428
12 375
13 114
7 633
12 943
12 479
11 723
12 688
13 674
13 321
Accumulated Depreciation
18 440
21 165
22 415
11 203
12 515
11 901
11 923
13 500
14 663
15 936
Intangible Assets
15 653
15 178
13 567
11 674
36 696
34 709
25 424
26 258
24 183
23 363
Goodwill
15 347
16 096
16 312
14 751
38 442
39 126
36 418
40 106
39 648
32 299
Note Receivable
317
329
409
475
1 500
1 501
1 506
2 005
1 902
2 189
Long-Term Investments
1 187
1 224
1 753
5 273
1 586
971
993
1 195
1 486
1 338
Other Long-Term Assets
4 075
4 894
6 636
5 208
4 500
4 949
5 065
5 411
6 224
6 193
Other Assets
15 347
16 096
16 312
14 751
38 442
39 126
36 418
40 106
39 648
32 299
Total Assets
70 234
N/A
73 917
+5%
82 238
+11%
75 087
-9%
126 732
+69%
126 174
0%
116 804
-7%
120 241
+3%
124 877
+4%
116 259
-7%
Liabilities
Accounts Payable
5 363
5 945
6 410
5 129
6 038
6 426
5 678
6 792
7 545
7 456
Accrued Liabilities
782
983
1 084
164
367
343
374
339
434
354
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1 443
2 468
2 889
1 050
2 958
1 975
8 359
3 053
7 539
4 704
Other Current Liabilities
7 747
7 584
8 154
7 250
13 762
14 471
22 357
19 219
19 566
16 943
Total Current Liabilities
15 503
16 980
18 537
13 593
23 125
23 215
36 768
29 403
35 084
29 457
Long-Term Debt
17 797
16 332
15 375
12 158
37 708
36 907
33 198
36 478
33 781
38 170
Deferred Income Tax
689
826
1 330
1 153
4 667
3 755
1 175
931
727
790
Minority Interest
112
1 180
1 564
60
171
180
152
148
153
151
Other Liabilities
16 027
14 334
15 099
11 322
15 084
14 864
14 988
20 261
16 359
14 764
Total Liabilities
50 128
N/A
49 652
-1%
51 905
+5%
38 286
-26%
80 755
+111%
78 921
-2%
86 281
+9%
87 221
+1%
86 104
-1%
83 332
-3%
Equity
Common Stock
2 117
2 117
2 117
2 117
2 387
2 515
2 515
2 515
2 515
2 515
Retained Earnings
11 822
15 981
18 558
25 026
25 739
26 151
13 059
13 345
17 233
12 175
Additional Paid In Capital
6 167
6 167
9 658
9 658
18 388
18 261
18 261
18 261
18 261
18 261
Unrealized Security Profit/Loss
0
0
0
0
122
310
117
212
112
81
Other Equity
0
0
0
0
659
16
3 429
1 313
652
105
Total Equity
20 106
N/A
24 265
+21%
30 333
+25%
36 801
+21%
45 977
+25%
47 253
+3%
30 523
-35%
33 020
+8%
38 773
+17%
32 927
-15%
Total Liabilities & Equity
70 234
N/A
73 917
+5%
82 238
+11%
75 087
-9%
126 732
+69%
126 174
0%
116 804
-7%
120 241
+3%
124 877
+4%
116 259
-7%
Shares Outstanding
Common Shares Outstanding
840
840
840
840
933
982
982
982
982
982

See Also

Summary
BAYN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BAYN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BAYN stock valuation using valuation multiples.
Wall Street Estimates
BAYN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BAYN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 129,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.